Cargando…
Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges
The Coronavirus Disease 2019 (COVID-19) pandemic is advancing globally, and pharmaceutical prophylaxis is one solution. Here, we propose repositioning chloroquine (CQ) as prophylaxis against COVID-19. CQ blocks viral attachment and entry to host cells and demonstrates efficacy against a variety of v...
Autores principales: | Chang, Raymond, Sun, Wei-Zen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831558/ https://www.ncbi.nlm.nih.gov/pubmed/32629169 http://dx.doi.org/10.1016/j.drudis.2020.06.030 |
Ejemplares similares
-
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020) -
Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms
por: Sanghai, Nitesh, et al.
Publicado: (2020) -
Rising to the challenge of COVID-19
por: Hofer, Ursula, et al.
Publicado: (2020) -
Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021) -
COVID-19 and Community Dental Services: The challenges ahead
por: Westgarth, David
Publicado: (2020)